---
title: THP-1 CDX Model - TD2 Precision Oncology
description: THP-1 stands as a crucial cell line for research on acute monocytic leukemia, uncovering the disease's molecular intricacies and driving therapeutic advances.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/thp-1.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# THP-1 CDX Model

The THP-1 cell line is derived from human acute monocytic leukemia, a subtype of acute myeloid leukemia (AML). AML is a heterogeneous hematological malignancy characterized by the rapid proliferation of immature myeloid cells, leading to impaired hematopoiesis and bone marrow failure. THP-1 serves as an indispensable tool for understanding the complex biology, progression, and therapeutic challenges associated with AML, particularly the monocytic subtype. Reflecting key molecular features and genetic mutations often seen in AML patients, THP-1 plays a vital role in preclinical research. Its in vitro and in vivo behavior provides deep insights into leukemic cell growth dynamics, interaction with the bone marrow microenvironment, and sensitivity to therapeutic agents. Researchers widely utilize the THP-1 model to study the molecular drivers of AML, assess the efficacy of potential therapeutic agents, and investigate resistance mechanisms to current treatments.

## Model Details

**Cancer Location:** Intravenous   
**Cancer Type:** Acute Myeloid Leukemia  
**Model Name:** THP-1  
**Mouse Strain:** NOG, NSG

## THP-1 Growth Curves

![THP-1 CDX Model](https://td2inc.com/hubfs/Assets/GraphsFigures/thp-1.png)

Growth of subcutaneous THP-1 in mice (n=5 mice)

### Request Additional CDX Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)